APO RESEARCH · REPORT
Arginine (Cas 74-79-3)
Arginine is a type of α-amino acid. The L-form is one of the 20 most common natural amino acids. A nonessential amino acid in human, Arginine is a substrate of nitric oxide synthase, which is converted to L-citrulline and nitric oxide (NO). It is widely used as an ingredient in dietary supplements, infusions and infant formulas.
Product & engineering
Understand the product.
Arginine is a type of α-amino acid. The L-form is one of the 20 most common natural amino acids. A nonessential amino acid in human, Arginine is a substrate of nitric oxide synthase, which is converted to L-citrulline and nitric oxide (NO). It is widely used as an ingredient in dietary supplements, infusions and infant formulas.
Selected research
Industry Research
Arginine (Cas 74-79-3) Industry Research Report 2026
Market perspective
Arginine is a type of α-amino acid. The L-form is one of the 20 most common natural amino acids. A nonessential amino acid in human, Arginine is a substrate of nitric oxide synthase, which is converted to L-citrulline and nitric oxide (NO). It is widely used as an ingredient in dietary supplements, infusions and infant formulas.
Europe is the largest region of Arginine (Cas 74-79-3), with a market share about 30%. It was followed by North America with 25%. Ajinomoto group, KYOWA, Daesang, Jingjing, Jinghai Amino Acid and Jiahe Biotech are the leaders of of industry, and they had about 50% combined market share.
Report Scope
Read the full market overview
This report quantifies the global Arginine (Cas 74-79-3) market in revenue (US$ million) and, where applicable, sales volume (t), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/t) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Arginine (Cas 74-79-3).
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Arginine (Cas 74-79-3) Market by Company
Ajinomoto Group
KYOWA
Daesang
CJ
JingJing
Jinghai Amino Acid
Jiahe Biotech
SHINE STAR
Xingyu Technology
Longteng Biotech
Arginine (Cas 74-79-3) Segment by Type
Food Grade
Pharma Grade
Others
Arginine (Cas 74-79-3) Segment by Application
Supplements & Nutrition
Pharmaceuticals
Cosmetics
Others
Arginine (Cas 74-79-3) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Arginine (Cas 74-79-3) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Arginine (Cas 74-79-3) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Arginine (Cas 74-79-3).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Arginine (Cas 74-79-3) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Arginine (Cas 74-79-3) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Arginine (Cas 74-79-3) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Food Grade
- Pharma Grade
- Others
Applications
- Supplements & Nutrition
- Pharmaceuticals
- Cosmetics
- Others
Companies covered
- Ajinomoto Group
- KYOWA
- Daesang
- CJ
- JingJing
- Jinghai Amino Acid
- Jiahe Biotech
- SHINE STAR
- Xingyu Technology
- Longteng Biotech
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Arginine (Cas 74-79-3) by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Food Grade
- 2.2.3 Pharma Grade
- 2.2.4 Others
- 2.3 Arginine (Cas 74-79-3) by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Supplements & Nutrition
- 2.3.3 Pharmaceuticals
- 2.3.4 Cosmetics
- 2.3.5 Others
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Arginine (Cas 74-79-3) Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Arginine (Cas 74-79-3) Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Arginine (Cas 74-79-3) Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Arginine (Cas 74-79-3) Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Arginine (Cas 74-79-3) Production by Manufacturers (2021-2026)
- 3.2 Global Arginine (Cas 74-79-3) Production Value by Manufacturers (2021-2026)
- 3.3 Global Arginine (Cas 74-79-3) Average Price by Manufacturers (2021-2026)
- 3.4 Global Arginine (Cas 74-79-3) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Arginine (Cas 74-79-3) Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Arginine (Cas 74-79-3) Manufacturers, Product Type & Application
- 3.7 Global Arginine (Cas 74-79-3) Manufacturers Established Date
- 3.8 Global Arginine (Cas 74-79-3) Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Ajinomoto Group
- 4.1.1 Ajinomoto Group Arginine (Cas 74-79-3) Company Information
- 4.1.2 Ajinomoto Group Arginine (Cas 74-79-3) Business Overview
- 4.1.3 Ajinomoto Group Arginine (Cas 74-79-3) Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Ajinomoto Group Product Portfolio
- 4.1.5 Ajinomoto Group Recent Developments
- 4.2 KYOWA
- 4.2.1 KYOWA Arginine (Cas 74-79-3) Company Information
- 4.2.2 KYOWA Arginine (Cas 74-79-3) Business Overview
- 4.2.3 KYOWA Arginine (Cas 74-79-3) Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 KYOWA Product Portfolio
- 4.2.5 KYOWA Recent Developments
- 4.3 Daesang
- 4.3.1 Daesang Arginine (Cas 74-79-3) Company Information
- 4.3.2 Daesang Arginine (Cas 74-79-3) Business Overview
- 4.3.3 Daesang Arginine (Cas 74-79-3) Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 Daesang Product Portfolio
- 4.3.5 Daesang Recent Developments
- 4.4 CJ
- 4.4.1 CJ Arginine (Cas 74-79-3) Company Information
- 4.4.2 CJ Arginine (Cas 74-79-3) Business Overview
- 4.4.3 CJ Arginine (Cas 74-79-3) Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 CJ Product Portfolio
- 4.4.5 CJ Recent Developments
- 4.5 JingJing
- 4.5.1 JingJing Arginine (Cas 74-79-3) Company Information
- 4.5.2 JingJing Arginine (Cas 74-79-3) Business Overview
- 4.5.3 JingJing Arginine (Cas 74-79-3) Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 JingJing Product Portfolio
- 4.5.5 JingJing Recent Developments
- 4.6 Jinghai Amino Acid
- 4.6.1 Jinghai Amino Acid Arginine (Cas 74-79-3) Company Information
- 4.6.2 Jinghai Amino Acid Arginine (Cas 74-79-3) Business Overview
- 4.6.3 Jinghai Amino Acid Arginine (Cas 74-79-3) Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Jinghai Amino Acid Product Portfolio
- 4.6.5 Jinghai Amino Acid Recent Developments
- 4.7 Jiahe Biotech
- 4.7.1 Jiahe Biotech Arginine (Cas 74-79-3) Company Information
- 4.7.2 Jiahe Biotech Arginine (Cas 74-79-3) Business Overview
- 4.7.3 Jiahe Biotech Arginine (Cas 74-79-3) Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 Jiahe Biotech Product Portfolio
- 4.7.5 Jiahe Biotech Recent Developments
- 4.8 SHINE STAR
- 4.8.1 SHINE STAR Arginine (Cas 74-79-3) Company Information
- 4.8.2 SHINE STAR Arginine (Cas 74-79-3) Business Overview
- 4.8.3 SHINE STAR Arginine (Cas 74-79-3) Production Capacity, Value and Gross Margin (2021-2026)
- 4.8.4 SHINE STAR Product Portfolio
- 4.8.5 SHINE STAR Recent Developments
- 4.9 Xingyu Technology
- 4.9.1 Xingyu Technology Arginine (Cas 74-79-3) Company Information
- 4.9.2 Xingyu Technology Arginine (Cas 74-79-3) Business Overview
- 4.9.3 Xingyu Technology Arginine (Cas 74-79-3) Production Capacity, Value and Gross Margin (2021-2026)
- 4.9.4 Xingyu Technology Product Portfolio
- 4.9.5 Xingyu Technology Recent Developments
- 4.10 Longteng Biotech
- 4.10.1 Longteng Biotech Arginine (Cas 74-79-3) Company Information
- 4.10.2 Longteng Biotech Arginine (Cas 74-79-3) Business Overview
- 4.10.3 Longteng Biotech Arginine (Cas 74-79-3) Production Capacity, Value and Gross Margin (2021-2026)
- 4.10.4 Longteng Biotech Product Portfolio
- 4.10.5 Longteng Biotech Recent Developments
5 Global Arginine (Cas 74-79-3) Production by Region
- 5.1 Global Arginine (Cas 74-79-3) Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Arginine (Cas 74-79-3) Production by Region: 2021-2032
- 5.2.1 Global Arginine (Cas 74-79-3) Production by Region: 2021-2026
- 5.2.2 Global Arginine (Cas 74-79-3) Production Forecast by Region (2027-2032)
- 5.3 Global Arginine (Cas 74-79-3) Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Arginine (Cas 74-79-3) Production Value by Region: 2021-2032
- 5.4.1 Global Arginine (Cas 74-79-3) Production Value by Region: 2021-2026
- 5.4.2 Global Arginine (Cas 74-79-3) Production Value Forecast by Region (2027-2032)
- 5.5 Global Arginine (Cas 74-79-3) Market Price Analysis by Region (2021-2026)
- 5.6 Global Arginine (Cas 74-79-3) Production and Value, YOY Growth
- 5.6.1 North America Arginine (Cas 74-79-3) Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Arginine (Cas 74-79-3) Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Arginine (Cas 74-79-3) Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Arginine (Cas 74-79-3) Production Value Estimates and Forecasts (2021-2032)
6 Global Arginine (Cas 74-79-3) Consumption by Region
- 6.1 Global Arginine (Cas 74-79-3) Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Arginine (Cas 74-79-3) Consumption by Region (2021-2032)
- 6.2.1 Global Arginine (Cas 74-79-3) Consumption by Region: 2021-2026
- 6.2.2 Global Arginine (Cas 74-79-3) Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Arginine (Cas 74-79-3) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Arginine (Cas 74-79-3) Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Arginine (Cas 74-79-3) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Arginine (Cas 74-79-3) Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Arginine (Cas 74-79-3) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Arginine (Cas 74-79-3) Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Arginine (Cas 74-79-3) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Arginine (Cas 74-79-3) Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Arginine (Cas 74-79-3) Production by Type (2021-2032)
- 7.1.1 Global Arginine (Cas 74-79-3) Production by Type (2021-2032) & (t)
- 7.1.2 Global Arginine (Cas 74-79-3) Production Market Share by Type (2021-2032)
- 7.2 Global Arginine (Cas 74-79-3) Production Value by Type (2021-2032)
- 7.2.1 Global Arginine (Cas 74-79-3) Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Arginine (Cas 74-79-3) Production Value Market Share by Type (2021-2032)
- 7.3 Global Arginine (Cas 74-79-3) Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Arginine (Cas 74-79-3) Production by Application (2021-2032)
- 8.1.1 Global Arginine (Cas 74-79-3) Production by Application (2021-2032) & (t)
- 8.1.2 Global Arginine (Cas 74-79-3) Production Market Share by Application (2021-2032)
- 8.2 Global Arginine (Cas 74-79-3) Production Value by Application (2021-2032)
- 8.2.1 Global Arginine (Cas 74-79-3) Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Arginine (Cas 74-79-3) Production Value Market Share by Application (2021-2032)
- 8.3 Global Arginine (Cas 74-79-3) Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Arginine (Cas 74-79-3) Value Chain Analysis
- 9.1.1 Arginine (Cas 74-79-3) Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Arginine (Cas 74-79-3) Production Mode & Process
- 9.2 Arginine (Cas 74-79-3) Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Arginine (Cas 74-79-3) Distributors
- 9.2.3 Arginine (Cas 74-79-3) Customers
10 Global Arginine (Cas 74-79-3) Analyzing Market Dynamics
- 10.1 Arginine (Cas 74-79-3) Industry Trends
- 10.2 Arginine (Cas 74-79-3) Industry Drivers
- 10.3 Arginine (Cas 74-79-3) Industry Opportunities and Challenges
- 10.4 Arginine (Cas 74-79-3) Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst